- Home
- NEN vs SOPH Comparison
NEN vs SOPH Comparison
Compare NEN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- SOPH
- Stock Information
- Founded
- NEN 1977
- SOPH 2011
- Country
- NEN United States
- SOPH Switzerland
- Employees
- NEN N/A
- SOPH N/A
- Industry
- NEN Building operators
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEN Real Estate
- SOPH Health Care
- Exchange
- NEN Nasdaq
- SOPH Nasdaq
- Market Cap
- NEN 248.2M
- SOPH 247.0M
- IPO Year
- NEN N/A
- SOPH 2021
- Fundamental
- Price
- NEN $81.00
- SOPH $3.14
- Analyst Decision
- NEN
- SOPH Strong Buy
- Analyst Count
- NEN 0
- SOPH 3
- Target Price
- NEN N/A
- SOPH $7.00
- AVG Volume (30 Days)
- NEN 335.0
- SOPH 37.0K
- Earning Date
- NEN 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- NEN 1.98%
- SOPH N/A
- EPS Growth
- NEN 71.00
- SOPH N/A
- EPS
- NEN 3.40
- SOPH N/A
- Revenue
- NEN $79,924,036.00
- SOPH $64,938,000.00
- Revenue This Year
- NEN N/A
- SOPH $7.70
- Revenue Next Year
- NEN N/A
- SOPH $20.61
- P/E Ratio
- NEN $23.80
- SOPH N/A
- Revenue Growth
- NEN 12.08
- SOPH 20.14
- 52 Week Low
- NEN $64.00
- SOPH $2.49
- 52 Week High
- NEN $84.00
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- NEN 53.34
- SOPH 33.65
- Support Level
- NEN $79.00
- SOPH $3.21
- Resistance Level
- NEN $81.00
- SOPH $4.10
- Average True Range (ATR)
- NEN 0.43
- SOPH 0.29
- MACD
- NEN -0.48
- SOPH -0.08
- Stochastic Oscillator
- NEN 50.00
- SOPH 8.15
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.